Program
5th Cancer Cachexia Conference –
Bridging Molecular Advances to Clinical Care
Updated: September 12, 2019
Friday, September 11, 2020
7:30 am Registration
(Montreal Grand Ballroom Foyet)
Note: All general sessions are held in the Montreal Grand Ballroom
PRE-MEETING –
Clinical Advances in Assessments and Management in Cancer Cachexia
Session A: Functional Outcome Measures for Cancer Cachexia
Chair: Dan Marks, MD, PhD - Oregon Health Sciences University, USA
8:20 am Introductory Remarks
8:30 am Speaker 1 – TBA (from requested abstracts)
9:00 am Speaker 2 – TBA (from requested abstracts)
9:30 am Jorge Nieva, MD
University of Southern California, USA
“Karnofsky Revisited – Measuring Performance Status in the Digital Age”
10:00 am Coffee Break
(Montreal Grand Ballroom Foyer)
Session B: Clinical Trial Results
10:30 am TBA
11:00 am Tora Solheim, PhD
St. Olavs Hospital, Trondheim University Hospital, Norway
11:30 am Jose Garcia, MD, PhD
University of Washington, USA
“Androgens in cancer cachexia: a new purpose for an old drug”
12:00 pm Short Talk 1 (selected from abstracts)
12:15 pm Short Talk 2 (selected from abstracts)
12:30 pm Lunch
Box lunches will be provided
Session C: Conversations with Caregivers and Patients
Moderator 1: Thomas R. Jagoe, MD – McGill University, Canada
Moderator 2: Patient from McGill Univeristy
1:30-2:30 pm Program for Caregivers and Patients
(Montreal Grand Ballroom)
2:30 pm Poster Set Up
(Montreal Grand Ballroom – Section D)
Session 1
Introductory Remarks and Keynote Address
Chair: Josep Argiles, PhD - University of Barcelona, Spain
(Montreal Grand Ballroom)
3:45 pm Introductions to the 5th Cancer Cachexia Conference
Denis C. Guttridge, PhD
Medical University of South Carolina, USA
4:00 pm Keynote Address
Annemie Schols, PhD
Masstricht University, Netherlands
5:00 pm Cutting Edge Science in Cancer Cachexia
Six speakers chosen from selected abstracts
5:30-7:30 pm Welcoming Reception
(Fortification Room)
7:30 pm Poster Viewing
(Montreal Grand Ballroom – Section D)
Saturday, September 12, 2020
6:30-8:30 am Breakfast
(Montreal Grand Ballroom Foyer)
Note: All general sessions are held in the Montreal Grand Ballroom
Session 2
Metabolic Dysfunction in Cancer Cachexia
Chair: TBA
8:30 am Speaker 7
9:00 am Stephan Herzig, PhD
Helmholtz Diabetes and Cancer Center, Germany
“Organ-specific metabolic programs in cancer cachexia”
Selected Short Talks
9:30 am Short Talk 3 (selected from abstracts)
9:45 am Short Talk 4 (selected from abstracts)
10:30 am Coffee Break
(Montreal Grand Ballroom Foyer)
Session 3
Mechanisms of Skeletal Muscle Wasting: Myofiber
Chair: Andy Judge, PhD - University of Florida, USA
11:00 am Paul Gregorevic, PhD
University of Melbourne, Australia
“Exploring and targeting new mechanisms implicated in muscle wasting associated with cancer cachexia”
11:30 am Imed Gallouzi, PhD
McGill University, CA
12:00 pm David Glass, MD
Novartis Institutes for Biomedical Research, USA
12:30 pm Lunch
(Fortification Room)
1:45-3:45 pm Poster Viewing
(Montreal Grand Ballroom – Section D)
Session 4
Nutrition Imbalance and Strategies in Cancer Cachexia
Chair: Richard Skipworth, MD - University of Edinburgh, United Kingdom
4:00 pm Speaker 19
4:30 pm Speaker 20
Selected Short Talks
5:00 pm Klaske Van Norren, PhD (selected from abstracts)
Wageningen University, Netherlands
5:15 pm Silvia Busquets, PhD (selected from abstracts)
University of Barcelona, Spain
5:30 pm End of program day
Sunday, September 13, 2019
6:30-8:30 am Breakfast
(Montreal Grand Ballroom Foyer)
Session 5
Identification of Biomarkers in Cancer Cachexia
Chair:
8:30 am Vera Mazurak, PhD
University of Calgary, Canada
"Moving forward with Human Muscle Evaluation: Proceed with Caution"
9:00 am David Thomas, MD
Broad Institute, USA
Selected Short Talks
9:30 am Bary Laird, PhD (selected from abstracts)
University of Edinburgh, UK
9:45 am Helen Heymann, MMSC (selected from abstracts)
Foundation for the National Institutes of Health, USA
10:00 am Coffee Break
Announcement of Poster Winners (3 basic science, 3 clinical science)
(Montreal Grand Ballroom Foyet)
Session 6
Next Generation Researchers in Cancer Cachexia
Chairs: Rishi Jain, MD, Fox Chase Cancer Center, USA
Cynthia Stretch, PhD, University of Calgary, CA
To promote upcoming and young faculty researchers: Speakers chosen from submitted applications
10:30 am Speaker 1 – TBA Tarah Ballinger, MD Indiana University, USA
10:45 am Speaker 2 – TBA
11:00 am Speaker 3 – TBA
11:15 am Speaker 4 – TBA
11:30 am Speaker 5 – TBA
11:45 am Speaker 6 – TBA Vanina Romanello, PhD Padua University, Italy
12:00 pm Lunch
(Fortification Room)
Session 7
Mechanisms of Muscle Wasting: Muscle Microenvironment
Chair: Marco Sandri, PhD - Padua University, Italy
1:30 pm Michael Rudnicki, PhD
University of Ottawa, CA
“Molecular regulation of stem cell function”
2:00 pm Azeddine Atfi, PhD
Virginia Commonwealth University, USA
2:30 pm Jerome Feige, PhD
Nestle, Switzerland
“Crosstalk in the muscle stem cell niche during aging and cachexia”
3:00 pm Coffee Break
(Montreal Grand Ballroom Foyet)
Session 8
Therapy-Induced Muscle Dysfunction and Wasting
Chair: Vickie Baracos, PhD, University of Alberta, Canada
3:30 pm
Andrea Bonetto, PhD – Indiana University, USA
“Mechanisms of chemotherapy-induced musculoskeletal complications”
4:00 pm
TBA
Selected Short Talks (selected from abstracts)
4:30 pm
David Waning, PhD – Pennsylvania State University, USA
4:45 pm
Short Talk 6
5:00 pm
Closing Remarks